Veterinary Medicines

KARIFLOX 25 mg/ml oral solution for calves

Authorised
  • Enrofloxacin
Download as PDF

Product identification

Medicine name:
KARIFLOX 25 mg/ml oral solution for calves
KARIFLOX 25 mg/ml SOLUCION ORAL PARA TERNEROS
Active substance:
  • Enrofloxacin
Target species:
  • Cattle
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Enrofloxacin
    25.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        11
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • Container Material:High density polyethylene bottlesContainer Closure:Polyethylene screw capContainer Colour:WhiteContainer Volume: 5 litreDosing Device:For all containers a 20 ml measuring device of polypropylene is included.
  • Container Material:High density polyethylene bottlesContainer Closure:Polyethylene screw capContainer Colour:WhiteContainer Volume: 1 litreDosing Device:For all containers a 20 ml measuring device of polypropylene is included.
  • Container Material:High density polyethylene bottlesContainer Closure:Polyethylene screw capContainer Colour:WhiteContainer Volume: 500 mlDosing Device:For all containers a 20 ml measuring device of polypropylene is included.
  • Container Material:High density polyethylene bottlesContainer Closure:Polyethylene screw capContainer Colour:WhiteContainer Volume: 250 mlDosing Device:For all containers a 20 ml measuring device of polypropylene is included.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Karizoo S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Karizoo S.A.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 2029 ESP
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0217/002
Concerned member states:
  • France
  • Germany
  • Netherlands
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
Spanish (PDF)
Published on: 16/02/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 16/02/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 16/02/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."